已收盘 11-14 16:00:00 美东时间
-1.630
-0.75%
Alexander's (NYSE:ALX) reported quarterly earnings of $2.91 per share which beat the analyst consensus estimate of $2.50 by 16.4 percent. This is a 2.46 percent increase over earnings of $2.84 per share from the same
11-03 22:30
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
11-03 19:11
Alexander's (NYSE:ALX) is gearing up to announce its quarterly earnings on Mond...
11-01 03:01
-Two poster presentations showcase best- and first-in-class potential of ALX2004, a novel, antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors-Robust body of preclinical data supports ALX2004
10-24 00:31
Aligos Therapeutics announced that its management will present at the H.C. Wainwright Liver Disease Conference on October 21-22, 2025. The presentation can be accessed via webcast on Aligos' website, with a replay available for 30 days. Aligos is a clinical-stage biotech company focused on developing best-in-class therapies for liver and viral diseases such as chronic HBV, MASH, and coronaviruses.
10-14 12:30
Atlas Arteria ( ($AU:ALX) ) just unveiled an announcement. Atlas Arteria announ...
10-13 06:27
Atlas Arteria ( ($AU:ALX) ) just unveiled an announcement. Atlas Arteria has an...
10-10 10:18
Atlas Arteria ( ($AU:ALX) ) has provided an update. Atlas Arteria announced a d...
09-19 07:18
Atlas Arteria ( ($AU:ALX) ) just unveiled an announcement. Atlas Arteria has an...
09-19 07:18
Monopar Therapeutics Inc. (NASDAQ:MNPR) announced that new data on the long-term neurological efficacy and safety of its investigational therapy ALXN1840 (tiomolybdate choline) for Wilson disease will be presented at the
09-14 20:15